首页> 外文OA文献 >PHS83 Potential Time Savings With Rituximab Subcutaneous (SC) Injection Versus Rituximab Intravenous (IV) Infusion: Results from Interviews at 13 European Sites As Part of a Time and Motion Study (TM)

【2h】

PHS83 Potential Time Savings With Rituximab Subcutaneous (SC) Injection Versus Rituximab Intravenous (IV) Infusion: Results from Interviews at 13 European Sites As Part of a Time and Motion Study (TM)

机译：PHS83利妥昔单抗皮下注射（SC）对比利妥昔单抗静脉注射（IV）可能节省的时间：作为时间和运动研究（T＆M）的一部分，来自13个欧洲地区的访谈结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
De cock E.; Carella A.M.; Tao S.; Wiesner C.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Microcosting Study of Rituximab Subcutaneous Injection Versus Intravenous Infusion [J] . Mihajlovic Jovan, Bax Pieter, van Breugel Erwin, Clinical therapeutics . 2017,第6期

机译：Rituximab皮下注射与静脉内输注的微栓塞研究
2. An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries [J] . Body Jean-Jacques, Gatta Francesca, De Cock Erwin, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2017,第9期

机译：转移性骨病患者Denosumab皮下注射和唑妥酸静脉输注的观察时间和运动研究：三个欧洲国家的结果
3. Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum] [J] . ClinicoEconomics and Outcomes Research . 2017,第10期

机译：基于系统性调查，意大利17家医院的非霍奇金淋巴瘤皮下注射和静脉注射利妥昔单抗和乳腺癌曲妥珠单抗的潜在资源和成本节省分析[勘误]
4. Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries [O] . Erwin De Cock, Persefoni Kritikou, Mariana Sandoval, -1

机译：利妥昔单抗皮下注射与利妥昔单抗静脉滴注节省时间：八个国家的时间和运动研究
5. RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion: Results from Interviews Conducted As Part of a Time-and-Motion Study (TM) Across 17 Sites [O] . De Cock E., Tao S., Urspruch A., 2012

机译：曲妥珠单抗皮下（SC）注射与曲妥珠单抗静脉（IV）输注相比RU2潜在的时间节省：在17个地点的时空运动研究（T＆M）中进行的访谈结果

PHS83 Potential Time Savings With Rituximab Subcutaneous (SC) Injection Versus Rituximab Intravenous (IV) Infusion: Results from Interviews at 13 European Sites As Part of a Time and Motion Study (TM)

著录项

相似文献

相关主题

期刊订阅